TrivarX Limited ( (AU:TRI) ) just unveiled an announcement.
TrivarX Limited has issued 896,057 ordinary fully paid shares to satisfy consulting fees, with the shares issued at prices of $0.019 and $0.017 each. This issuance was conducted without disclosure to investors under the Corporations Act, and the company has confirmed compliance with relevant legal provisions, indicating no excluded information that would affect investor assessments.
More about TrivarX Limited
TrivarX Limited is a mental health technology company that focuses on using objective measures for the early detection and screening of mental health conditions. Founded in Australia, the company operates with offices in Perth and Minneapolis and is listed on the Australian Securities Exchange and the OTCQB Venture Market.
Technical Sentiment Signal: Buy
Current Market Cap: $3.52M
Find detailed analytics on TRI stock on TipRanks’ Stock Analysis page.